跳至主要内容
临床试验/NCT06809868
NCT06809868招募中不适用

Role of Transposable Elements in Septic Immune Aging

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2025年2月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
116
试验地点
1
主要终点
Immune Aging

研究概览

简要总结

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is:

  1. Do transposable elements prematurely age the immune systems of patients with sepsis?
  2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU?
  3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU?

Participants will have blood drawn from them but will not be subjected to additional interventions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 18 or older
  • •Admitted to ICU with sepsis (Sepsis 3 Criteria)
  • •SOFA score of at least 2 at time of enrollment

排除标准

  • •Patients on organ transplantation immunosuppression
  • •Patients with preexisting leukopenia
  • •Cancer patients receiving CAR-T therapy
  • •Patients who are under 18 years of age or otherwise deemed pediatric
  • •Patients with an ongoing bleeding diathesis (ie: DIC, hemorrhagic shock)
  • •Patients with a chronic hemoglobin below 7.0
  • •Patients who, prior to their ICU admission, are blood transfusion dependent

研究组 & 干预措施

Healthy Individual Controls

Healthy individuals not admitted to the hospital.

干预措施: RNA and DNA Sequencing (Genetic)

Patients with Sepsis

Adult patients (age 18 and older) admitted to the intensive care unit (ICU) meeting Sepsis 3 Criteria.

干预措施: RNA and DNA Sequencing (Genetic)

结局指标

主要结局

Immune Aging

时间窗: 6 weeks

次要结局

  • Mortality (30-day)(30 days)
  • Secondary Infection(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验